Category

Oral Drugs Recalls

5,039 oral drugs recalls on record from CPSC, FDA, and USDA.

5,039 recalls
High RiskFDA
Preferred Pharmaceuticals, Inc.
Montelukast Sodium Tablets, USP, 10 mg, packaged in: a) 30-count bottle (NDC 68788-9438-3); b) 60-count bottle (NDC 68788-9438-6); c) 90-...
Oral Drugs·266 affected·Mar 23, 2023
High RiskFDA
Preferred Pharmaceuticals, Inc.
Atorvastatin Calcium Tablets, USP, 20 mg, packaged in: a) 90-count bottle (NDC 68788-7631-9); b) 30-count bottle (NDC 68788-7631-3), Rx o...
Oral Drugs·375 affected·Mar 23, 2023
High RiskFDA
Preferred Pharmaceuticals, Inc.
Pravastatin Sodium Tablets, USP, 20 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-...
Oral Drugs·24 affected·Mar 23, 2023
High RiskFDA
Preferred Pharmaceuticals, Inc.
Simvastatin Tablets, USP, 10 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC 68788-9747-9
Oral Drugs·82 affected·Mar 23, 2023
High RiskFDA
Preferred Pharmaceuticals, Inc.
Glimepiride Tablets, USP, 2 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-8095-9
Oral Drugs·17 affected·Mar 23, 2023
High RiskFDA
Preferred Pharmaceuticals, Inc.
Simvastatin Tablets, USP, 20 mg, Packaged as: a) 90-count bottle (NDC 68788-9869-9); b) 60-count bottle (NDC 68788-9869-6); c) 30-count b...
Oral Drugs·305 affected·Mar 23, 2023
High RiskFDA
Preferred Pharmaceuticals, Inc.
Clopidogrel Tablets USP, 75 mg, 90-count bottles, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-8190-9
Oral Drugs·72 affected·Mar 23, 2023
High RiskFDA
Preferred Pharmaceuticals, Inc.
Doxazosin Tablets, USP, 2 mg, 100-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7328-1
Oral Drugs·3 affected·Mar 23, 2023
High RiskFDA
Preferred Pharmaceuticals, Inc.
Simvastatin Tablets, USP, 40 mg, Packaged as: a) 90-count bottle (NDC 68788-9868-9); b) 60-count bottle (NDC 68788-9868-6); c) 30-count b...
Oral Drugs·88 affected·Mar 23, 2023
High RiskFDA
Preferred Pharmaceuticals, Inc.
Rosuvastatin Tablets, USP, 10 mg, Packaged as: a) 30-count bottle (NDC 68788-7086-3); b) 90-count bottle (NDC 68788-7086-9), Rx only, Man...
Oral Drugs·59 affected·Mar 23, 2023
High RiskFDA
Preferred Pharmaceuticals, Inc.
Finasteride Tablets, USP, 5 mg, packaged in: a) 30-count bottles (NDC 68788-6976-3); b) 90-count bottles (NDC 68788-6976-9), Rx only, Man...
Oral Drugs·135 affected·Mar 23, 2023
High RiskFDA
Remedyrepack Inc.
Simvastatin 10 mg tablets, packaged in a) 30-count bottles (NDC 70518-0064-01) and b) 90-count bottles (NDC 70518-0064-00), Rx only, Repa...
Oral Drugs·1,262 affected·Mar 20, 2023
High RiskFDA
Remedyrepack Inc.
Ropinirole 2mg tablets, packaged in 180-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC70518-2750-00
Oral Drugs·3 affected·Mar 20, 2023
High RiskFDA
Remedyrepack Inc.
Simvastatin 40 mg tablets, packaged in a) 30-count bottles (NDC 70518-0060-01) and b) 90-count bottles (NDC 70518-0060-00), Rx only, Repa...
Oral Drugs·0 affected·Mar 20, 2023
High RiskFDA
Remedyrepack Inc.
Atorvastatin 10 mg tablets, packaged in a) 30-count bottles (NDC 70518-1946-00) and b) 90-count bottles (NDC 70518-1946-01), Rx only, Rep...
Oral Drugs·3,497 affected·Mar 20, 2023
High RiskFDA
Remedyrepack Inc.
Glimepiride 2 mg tablets, packaged in a) 30-count bottles (NDC 70518-0405-03), b) 90-count bottles (NDC 70518-0405-00) and c)180-count bo...
Oral Drugs·147 affected·Mar 20, 2023
High RiskFDA
Remedyrepack Inc.
Tadalafil 5 mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2972-00
Oral Drugs·16 affected·Mar 20, 2023
High RiskFDA
Remedyrepack Inc.
Atorvastatin 20 mg tablets, packaged in a) 30-count bottles (NDC 70518-1977-00) and b)90-count bottles (NDC 70518-1977-01), Rx only, Repa...
Oral Drugs·3,426 affected·Mar 20, 2023
High RiskFDA
Remedyrepack Inc.
Rosuvastatin 40mg tablets, packaged in a) 45-count bottles (NDC 70518-1311-01), and b) 90-count bottles (NDC 70518-0484-00), Rx only, Rep...
Oral Drugs·76 affected·Mar 20, 2023
High RiskFDA
Remedyrepack Inc.
Rosuvastatin 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-3519-00.
Oral Drugs·399 affected·Mar 20, 2023
High RiskFDA
Remedyrepack Inc.
Doxazosin 2 mg tablets, packaged in a) 30-count (NDC 70518-1560-00) and b) 90-count bottles (NDC 70518-1560-01), Rx only, Repackaged by...
Oral Drugs·58 affected·Mar 20, 2023
High RiskFDA
Remedyrepack Inc.
Rosuvastatin 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-3519-00
Oral Drugs·132 affected·Mar 20, 2023
High RiskFDA
Remedyrepack Inc.
Aripiprazole 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2921-03
Oral Drugs·3 affected·Mar 20, 2023
High RiskFDA
Remedyrepack Inc.
Rosuvastatin 10mg tablets, packaged in a) 30-count bottles (NDC 70518-0375-03 and 70518-0375-01) and b) 90-count bottles (NDC 70518-0375-...
Oral Drugs·399 affected·Mar 20, 2023
High RiskFDA
Remedyrepack Inc.
Ropinirole 0.5 mg tablets, packaged in 90-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2439-00.
Oral Drugs·17 affected·Mar 20, 2023
High RiskFDA
Amerisource Health Services Llc
Glimepiride Tablets, USP, 4 mg, RX, Packaged as a) 100-count bottle, NDC# 68001-179-00; b) 500-count bottle, NDC# 68001-179-03, Manufactu...
Oral Drugs·129,849 affected·Mar 17, 2023
High RiskFDA
Amerisource Health Services Llc
Glimepiride Tablets, USP, 2 mg, RX, Packaged as a ) 100-count bottle, NDC# 68001-178-00; b) 500-count bottle; NDC# 68001-178-03 Manufact...
Oral Drugs·105,361 affected·Mar 17, 2023
High RiskFDA
Ascend Laboratories, Llc
Aripiprazole Tablets, USP, 20 mg, Rx Only, Packaged in 500-count bottle Manufactured by: Alkem Laboratories Ltd., INDIA Distributed by:...
Oral Drugs·135 affected·Mar 17, 2023
High RiskFDA
Amerisource Health Services Llc
Glimepiride Tablets, USP, 1 mg, RX, Packaged as a)100-count bottle, NDC# 68001-177-00; b) 500-count bottle, NDC# 68001-177-03; Manufactur...
Oral Drugs·63,335 affected·Mar 17, 2023
High RiskFDA
Northwind Pharmaceuticals Llc
Tadalafil Tablets, USP 20 mg, packaged in a) 6-count bottles (NDC 51655-473-87), and b) 15-count bottles (NDC 51655-473-54), Rx Only, Rep...
Oral Drugs·164 affected·Mar 16, 2023
High RiskFDA
Northwind Pharmaceuticals Llc
BusPIRone Hydrochloride Tablets USP, 7.5 mg, 30-count bottles, Rx Only, Repackaged By: NOrthwind Pharmaceuticals, Indianapolis, IN 46203....
Oral Drugs·6 affected·Mar 16, 2023
High RiskFDA
Northwind Pharmaceuticals Llc
Glimepiride Tablets, USP 2mg, packaged in a) 30-count bottles (NDC 51655-383-52), and b)90-count bottles (NDC 51655-383-26), Rx Only, Rep...
Oral Drugs·230 affected·Mar 16, 2023
High RiskFDA
Northwind Pharmaceuticals Llc
Atorvastatin Calcium Tablets, USP, 10 mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203. N...
Oral Drugs·99 affected·Mar 16, 2023
High RiskFDA
Northwind Pharmaceuticals Llc
Doxazosin Tablets, USP, 4mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203. NDC 51655-109-52
Oral Drugs·33 affected·Mar 16, 2023
High RiskFDA
Amerisource Health Services Llc
Verapamil Hydrochloride Extended-Release Tablets, USP, 180 mg, 100 Tablets (10 x 10) per carton, Rx only, Distributed by: American Health...
Oral Drugs·695 affected·Mar 16, 2023
High RiskFDA
Northwind Pharmaceuticals Llc
Tadalafil Tablets, USP 5 mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203. NDC 51655-487-52
Oral Drugs·23 affected·Mar 16, 2023
High RiskFDA
Northwind Pharmaceuticals Llc
Glimepiride Tablets, USP 4mg, packaged in a) 30-count bottles (NDC 51655-120-52), and b) 90-count bottles (NDC 51655-120-26), Rx Only, Re...
Oral Drugs·198 affected·Mar 16, 2023
High RiskFDA
Ascend Laboratories, Llc
Dabigatran Etexilate 150mg Capsules, 150 mg, Rx Only, 60 Capsules per bottle, Manufactured by: Alkem Laboratories Ltd., INDIA, Distribut...
Oral Drugs·12,804 affected·Mar 14, 2023
High RiskFDA
Ascend Laboratories, Llc
Dabigatran Etexilate Capsules, 75 mg, Rx Only, 60 Capsules per bottle, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: A...
Oral Drugs·13,560 affected·Mar 14, 2023
High RiskFDA
Hetero Usa Inc
Pantoprazole Sodium Delayed Release Tablets USP 40mg, 1000-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals Inc., Piscata...
Oral Drugs·2,352 affected·Mar 14, 2023
High RiskFDA
Direct Rx
Glimepiride, USP, 1 mg Tablets, Rx Only, Packaged as a a) 30-count bottle, NDC 61919-0723-30; b) 90-count bottle, NDC 61919-0723-90 Packa...
Oral Drugs·30 affected·Mar 13, 2023
High RiskFDA
Direct Rx
Simvastatin, USP, 5 mg Tablets, Rx Only, Packaged as a 90-count bottle, NDC 61919-0710-90 Packaged and Distributed By: Direct Rx, Dawsonv...
Oral Drugs·51 affected·Mar 13, 2023
High RiskFDA
Direct Rx
Ropinirole, USP, 0.25 mg Tablets, Rx Only, Packaged as a 30-count bottle, NDC 72189-0364-30; Packaged and Distributed By: Direct Rx, Daws...
Oral Drugs·9 affected·Mar 13, 2023
High RiskFDA
Direct Rx
Glimepiride, USP, 4 mg Tablets, Rx Only, Packaged as a a) 30-count bottle, NDC 61919-0250-30; b) 90-count bottle, NDC 61919-0250-90 Packa...
Oral Drugs·30 affected·Mar 13, 2023
High RiskFDA
Direct Rx
Glimepiride, USP, 2 mg Tablets, Rx Only, Packaged as a a) 30-count bottle, NDC 61919-0488-30; b) 90-count bottle, NDC 61919-0448-90 Packa...
Oral Drugs·30 affected·Mar 13, 2023
High RiskFDA
Direct Rx
Ropinirole, USP, 1 mg Tablets, Rx Only, Packaged as a 30-count bottle, NDC 72189-0364-30; Packaged and Distributed By: Direct Rx, Dawsonv...
Oral Drugs·4 affected·Mar 13, 2023
CriticalFDA
Camber Pharmaceuticals Inc.
Atovaquone Oral Suspension USP, 750 mg/5 mL, Packaged in 210 mL bottle, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08...
Oral Drugs·1,568 affected·Mar 13, 2023
High RiskFDA
Direct Rx
Simvastatin, USP, 10 mg Tablets, Rx Only, Packaged as a a) 30-count bottle, NDC 61919-0688-30 b) 90-count bottle, NDC61919-0688-90, Packa...
Oral Drugs·30 affected·Mar 13, 2023